CA 19.9 is useful to monitor the response to treatment and if elevated suggests recurrence in patients with Pancreatic Cancer. Elevated concentrations are not specific. Use in patients with other medical conditions is not advised.
- No special preparation required
Clinico Diagnostic Centre is committed towards a common goal of achieving total Patient Care and Confidence by delivering excellent diagnostic reports and clinical services. This committment and responsibility is practised and communicated by the Top Management through. Achieving the likelihood of desired health outcomes that are consistent with current professional knowledge.